Title : Sorafenib combined with gemcitabine in EGFR-TKI-resistant human lung cancer cells.

Pub. Date : 2013 Jan

PMID : 23255896






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The molecular mechanism of this synergism is that RAF/MEK/ERK which are activated by gemcitabine are efficiently suppressed by simultaneously administered sorafenib. Sorafenib zinc fingers and homeoboxes 2 Homo sapiens